Christopher Nelson

Insider Reports History

Entity
Individual
Location
420 Royal Palm Way, Suite #100, Palm Beach, FL
Signature
/s/ Christopher Nelson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Nelson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
QSAM Biosciences, Inc. General Counsel & Executive VP Common Stock 0 $0 $3.00 May 2, 2024 Direct
QSAM Biosciences, Inc. General Counsel & Executive VP Series B 4.56K Jun 23, 2023 Direct
QSAM Biosciences, Inc. General Counsel & Executive VP Options to buy common stock 255 Feb 6, 2024 Direct
QSAM Biosciences, Inc. General Counsel & Executive VP Series B Convertible Preferred Stock 0 Feb 6, 2024 Direct

Insider Reports Filed by Christopher Nelson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QSAM QSAM Biosciences, Inc. May 2, 2024 1 $0 4 May 2, 2024 General Counsel & Executive VP
QSAM QSAM Biosciences, Inc. Feb 6, 2024 2 $0 4/A Feb 14, 2024 EVP Corp Dev & General Counsel
QSAM QSAM Biosciences, Inc. Feb 6, 2024 2 $0 4 Feb 13, 2024 EVP Corp Dev & General Counsel
QSAM QSAM Biosciences, Inc. Jun 23, 2023 1 $0 4 Jun 23, 2023 EVP Corp Dev & General Counsel
QSAM QSAM Biosciences, Inc. Dec 31, 2022 1 $0 4 Jan 4, 2023 General Counsel
QSAM QSAM Biosciences, Inc. Mar 3, 2022 1 $0 4 Mar 7, 2022 General Counsel
QSAM QSAM Biosciences, Inc. Dec 31, 2021 6 $400K 5 Feb 14, 2022 General Counsel and Director, Director